Drug Type Chemical drugs |
Synonyms- |
Target |
Mechanism BRD4 inhibitors(Bromodomain-containing protein 4 inhibitors), BTK inhibitors(Tyrosine-protein kinase BTK inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H20N2O5S |
InChIKeyMDJZBGKTJDDFOO-UHFFFAOYSA-N |
CAS Registry2409965-28-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Mantle-Cell Lymphoma | Preclinical | US | 15 Jan 2022 |